Clinical Trials on Glabellar Crease
Total 10000 results
-
Hoffmann-La RocheTerminatedMetastatic Breast CancerSpain, Korea, Republic of, China, Croatia, Italy, Colombia, Finland, United Kingdom, United States, Canada, Philippines, Australia, Norway, France, Poland, Turkey, Russian Federation, Brazil, Portugal
-
SOLTI Breast Cancer Research GroupMerck Sharp & Dohme LLCTerminated
-
Henry Ford Health SystemActive, not recruitingBreast Cancer FemaleUnited States
-
IRCCS San RaffaeleIBFM- Consiglio Nazionale delle RicercheCompletedBreast Cancer | Sentinel Lymph Node | Early-stage Breast CancerItaly
-
University of HailCompleted
-
Ma Fei，MDEnrolling by invitation
-
Zhejiang Cancer HospitalCompletedBreast Cancer MetastaticChina
-
TerSera Therapeutics LLCApproved for marketingHER2-positive Breast Cancer | HER2-positive Carcinoma
-
Centro di Riferimento Oncologico - AvianoCompletedBreast Cancer FemaleItaly
-
Oslo University HospitalBristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive TumorNorway, Belgium
-
Ain Shams UniversityCompleted
-
GE HealthcareMedpace, Inc.; Zionexa; Simbec-Orion GroupTerminatedMetastatic Breast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
University of Colorado, DenverNational Cancer Institute (NCI)WithdrawnBreast Cancer FemaleUnited States
-
Sunnybrook Health Sciences CentreCompletedInvasive Breast CancerCanada
-
Spanish Breast Cancer Research GroupInstituto de Salud Carlos IIICompletedInvasive Breast Cancer Between 2002 and 2005Spain
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom
-
University of Kansas Medical CenterCompletedBreast Cancer FemaleUnited States
-
Hanmi Pharmaceutical Company LimitedCompletedMetastatic Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
Genentech, Inc.Completed
-
Centre Leon BerardMerck Sharp & Dohme LLCCompleted
-
Oslo University HospitalCompletedBreast Cancer SurgeryNorway
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
UNC Lineberger Comprehensive Cancer CenterWithdrawnMetastatic Breast CancerUnited States
-
University of ArkansasOSI PharmaceuticalsTerminated
-
Yale UniversityNovartis; Genentech, Inc.TerminatedBreast Cancer | Hormone-Sensitive Breast CancerUnited States
-
Genesis Pharma S.A.Completed
-
Hospital General Universitario Gregorio MarañonCompletedMetastatic Breast CancerSpain
-
Asan Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedBreast Cancer RecurrentChina
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
University College, LondonNational Institute for Health Research, United KingdomUnknownEarly Breast CancerFrance, Korea, Republic of, United Kingdom, Italy, United States, China, Malaysia, Saudi Arabia, South Africa, Spain, Switzerland, Thailand
-
Tracon Pharmaceuticals Inc.United States Department of Defense; Roswell Park Cancer InstituteCompletedMetastatic Breast CancerUnited States
-
Polyphor Ltd.CompletedMetastatic Breast CancerSpain, United States
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Western Regional Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Samsung Medical CenterKorean Cancer Study GroupCompletedAdvanced Breast CancerKorea, Republic of
-
University of Kansas Medical CenterGlaxoSmithKline; NovartisUnknownMetastatic Breast CancerUnited States
-
University Hospital of CreteCompleted
-
University Health Network, TorontoTerminatedMetastatic Breast CancerCanada
-
Janssen Diagnostics, LLCThe Cleveland ClinicWithdrawnBreast Cancer | Metastatic Breast CancerUnited States
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknownErbB2-Positive Stage I-III Breast CancerSingapore
-
Jeroen Bosch ZiekenhuisBorstkanker Onderzoek Groep; Comprehensive Cancer Centre The NetherlandsTerminatedMetastatic Breast CancerNetherlands
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
AstraZenecaCompletedMetastatic Breast CancerBulgaria
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedMetastatic Breast CancerUnited States, Mexico
-
Health Outcomes SolutionsCompletedMetastatic Breast CancerUnited States